{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:59Z","timestamp":1790774339762,"version":"4.1.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human endogenous retroviruses (HERVs), constituting approximately 8% of the human genome, represent genomic remnants of ancestral retroviral infections that colonized the germline through evolutionary processes. While most HERVs remain epigenetically silenced, their reactivation through environmental stimuli or epigenetic dysregulation enables participation in oncogenesis via viral mimicry, immunomodulation, and insertional mutagenesis. Substantial evidence now implicates aberrant HERVs activity across urologic malignancies\u2014including prostate cancer, renal cell carcinoma (RCC), bladder cancer, and testicular germ cell tumors\u2014where cancer-type-specific mechanisms drive tumor development and progression. These encompass androgen-responsive HERV-K activation in prostate malignancies, hypoxia-inducible factor-mediated ERV immunogenicity in RCC, HERV-derived microRNA silencing of tumor suppressors in bladder cancer, and DNA hypomethylation-associated HERV expression in testicular germ cell tumors. This review synthesizes fundamental HERV biology with recent advances in their diagnostic and therapeutic applications for urologic neoplasms. Key clinical translations include ERV-based stratification models predicting immune checkpoint inhibitor response in metastatic RCC, HERV-E-targeted adoptive T cell therapies, and noncoding RNA biomarkers for early bladder cancer detection. We further discuss unresolved mechanistic paradoxes such as contradictory prognostic associations between HERV superfamily expression and PBRM1 inactivation in RCC, concluding with priorities for future research: validating HERV-derived neoantigens in immunotherapy platforms, optimizing epigenetic priming strategies to enhance viral mimicry effects, and establishing standardized HERV signatures as clinical biomarkers through multi-institutional cohorts.<\/jats:p>","DOI":"10.1038\/s41420-025-02820-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:11:47Z","timestamp":1764342707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The expression, regulation, and function of human endogenous retroviruses in genitourinary cancers"],"prefix":"10.1038","volume":"11","author":[{"given":"Wenjie","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chencheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudukelimu","family":"Abudushataer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paerhati","family":"Tuerxun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2361-2179","authenticated-orcid":false,"given":"Zheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-9214","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-9473","authenticated-orcid":false,"given":"Yu-Zheng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"2820_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2021.12.028","volume":"185","author":"J Jakobsson","year":"2022","unstructured":"Jakobsson J, Vincendeau M. SnapShot: human endogenous retroviruses. Cell. 2022;185:400\u2013400.e401","journal-title":"Cell"},{"key":"2820_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-019-0189-2","volume":"17","author":"WE Johnson","year":"2019","unstructured":"Johnson WE. Origins and evolutionary consequences of ancient endogenous retroviruses. Nat Rev Microbiol. 2019;17:355\u2013370.","journal-title":"Nat Rev Microbiol"},{"key":"2820_CR3","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1016\/j.molcel.2023.10.036","volume":"83","author":"D Torre","year":"2023","unstructured":"Torre D, Fstkchyan YS, Ho JSY, Cheon Y, Patel RS, Degrace EJ, et al. Nuclear RNA catabolism controls endogenous retroviruses, gene expression asymmetry, and dedifferentiation. Mol Cell. 2023;83:4255\u20134271.e4259","journal-title":"Mol Cell"},{"key":"2820_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102392","volume":"99","author":"ST Censi","year":"2024","unstructured":"Censi ST, Mariani-Costantini R, Granzotto A, Tomassini V, Sensi SL. Endogenous retroviruses in multiple sclerosis: a network-based etiopathogenic model. Ageing Res Rev. 2024;99:102392.","journal-title":"Ageing Res Rev"},{"key":"2820_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26630-z","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Sam TW, Lee AY, Leung D. Mouse strain-specific polymorphic provirus functions as cis-regulatory element leading to epigenomic and transcriptomic variations. Nat Commun. 2021;12:6462.","journal-title":"Nat Commun"},{"key":"2820_CR6","doi-asserted-by":"publisher","first-page":"e164397","DOI":"10.1172\/JCI164397","volume":"133","author":"J Attig","year":"2023","unstructured":"Attig J, Pape J, Doglio L, Kazachenka A, Ottina E, Young GR, et al. Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin. J Clin Investig. 2023;133:e164397","journal-title":"J Clin Investig"},{"key":"2820_CR7","doi-asserted-by":"publisher","first-page":"e3001826","DOI":"10.1371\/journal.pbio.3001826","volume":"20","author":"A Burn","year":"2022","unstructured":"Burn A, Roy F, Freeman M, Coffin JM. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues. PLoS Biol. 2022;20:e3001826.","journal-title":"PLoS Biol"},{"key":"2820_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virs.2022.01.019","volume":"37","author":"J Zheng","year":"2022","unstructured":"Zheng J, Wei Y, Han GZ. The diversity and evolution of retroviruses: Perspectives from viral \u201cfossils\u201d. Virol Sin. 2022;37:11\u201318.","journal-title":"Virol Sin"},{"key":"2820_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coviro.2017.06.006","volume":"25","author":"A Hayward","year":"2017","unstructured":"Hayward A. Origin of the retroviruses: when, where, and how? Curr Opin Virol. 2017;25:23\u201327.","journal-title":"Curr Opin Virol"},{"key":"2820_CR10","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249.","journal-title":"CA Cancer J Clin"},{"key":"2820_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41585-020-00389-2","volume":"18","author":"AF van de Merbel","year":"2021","unstructured":"van de Merbel AF, van der Horst G, van der Pluijm G. Patient-derived tumour models for personalized therapeutics in urological cancers. Nat Rev Urol. 2021;18:33\u201345.","journal-title":"Nat Rev Urol"},{"key":"2820_CR12","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u2013436.","journal-title":"CA Cancer J Clin"},{"key":"2820_CR13","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052\u20132090.","journal-title":"Lancet"},{"key":"2820_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.semcancer.2022.05.014","volume":"86","author":"C Li","year":"2022","unstructured":"Li C, Zeng X, Qiu S, Gu Y, Zhang Y. Nanomedicine for urologic cancers: diagnosis and management. Semin Cancer Biol. 2022;86:463\u2013475.","journal-title":"Semin Cancer Biol"},{"key":"2820_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02357-4","volume":"22","author":"N Jansz","year":"2021","unstructured":"Jansz N, Faulkner GJ. Endogenous retroviruses in the origins and treatment of cancer. Genome Biol. 2021;22:147.","journal-title":"Genome Biol"},{"key":"2820_CR16","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.3390\/ijms21144843","volume":"21","author":"A Vergara Bermejo","year":"2020","unstructured":"Vergara Bermejo A, Ragonnaud E, Daradoumis J, Holst P. Cancer associated endogenous retroviruses: ideal immune targets for adenovirus-based immunotherapy. Int J Mol Sci. 2020;21:4843.","journal-title":"Int J Mol Sci"},{"key":"2820_CR17","doi-asserted-by":"publisher","first-page":"Mdna3","DOI":"10.1128\/microbiolspec.MDNA3-0009-2014","volume":"3","author":"DL Mager","year":"2015","unstructured":"Mager DL, Stoye JP. Mammalian endogenous retroviruses. Microbiol Spectr. 2015;3:Mdna3\u20130009-2014.","journal-title":"Microbiol Spectr"},{"key":"2820_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrmicro2783","volume":"10","author":"JP Stoye","year":"2012","unstructured":"Stoye JP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol. 2012;10:395\u2013406.","journal-title":"Nat Rev Microbiol"},{"key":"2820_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3892\/ol.2020.12382","volume":"21","author":"Y Gao","year":"2021","unstructured":"Gao Y, Yu XF, Chen T. Human endogenous retroviruses in cancer: expression, regulation and function. Oncol Lett. 2021;21:121.","journal-title":"Oncol Lett"},{"key":"2820_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/neuonc\/noab142","volume":"23","author":"AH Shah","year":"2021","unstructured":"Shah AH, Gilbert M, Ivan ME, Komotar RJ, Heiss J, Nath A. The role of human endogenous retroviruses in gliomas: from etiological perspectives and therapeutic implications. Neuro Oncol. 2021;23:1647\u20131655.","journal-title":"Neuro Oncol"},{"key":"2820_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/apm.12489","volume":"124","author":"M Escalera-Zamudio","year":"2016","unstructured":"Escalera-Zamudio M, Greenwood AD. On the classification and evolution of endogenous retrovirus: human endogenous retroviruses may not be \u2018human\u2019 after all. APMIS. 2016;124:44\u201351.","journal-title":"APMIS"},{"key":"2820_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105727","volume":"116","author":"J Viot","year":"2025","unstructured":"Viot J, Loyon R, Adib N, Laurent-Puig P, de Reynies A, Andre F, et al. Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases. EBioMedicine. 2025;116:105727.","journal-title":"EBioMedicine"},{"key":"2820_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41392-023-01626-x","volume":"8","author":"Y Fang","year":"2023","unstructured":"Fang Y, Zhang MC, He Y, Li C, Fang H, Xu PP, et al. Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8:381.","journal-title":"Signal Transduct Target Ther"},{"key":"2820_CR24","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.3390\/ijms22147263","volume":"22","author":"F Licastro","year":"2021","unstructured":"Licastro F, Porcellini E. Activation of endogenous retrovirus, brain infections and environmental insults in neurodegeneration and Alzheimer\u2019s disease. Int J Mol Sci. 2021;22:7263.","journal-title":"Int J Mol Sci"},{"key":"2820_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1667\/RR2888.1","volume":"178","author":"JR Lee","year":"2012","unstructured":"Lee JR, Ahn K, Kim YJ, Jung YD, Kim HS. Radiation-induced human endogenous retrovirus (HERV)-R ENV gene expression by epigenetic control. Radiat Res. 2012;178:379\u2013384.","journal-title":"Radiat Res"},{"key":"2820_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/CMR.0b013e32833c1b5d","volume":"20","author":"J Reiche","year":"2010","unstructured":"Reiche J, Pauli G, Ellerbrok H. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 2010;20:435\u2013440.","journal-title":"Melanoma Res"},{"key":"2820_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12011-018-1605-6","volume":"191","author":"A Karimi","year":"2019","unstructured":"Karimi A, Sheervalilou R, Kahroba H. A new insight on activation of human endogenous retroviruses (HERVs) in malignant melanoma upon exposure to CuSO4. Biol Trace Elem Res. 2019;191:70\u201374.","journal-title":"Biol Trace Elem Res"},{"key":"2820_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41591-018-0116-5","volume":"24","author":"I Canadas","year":"2018","unstructured":"Canadas I, Thummalapalli R, Kim JW, Kitajima S, Jenkins RW, Christensen CL, et al. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med. 2018;24:1143\u20131150.","journal-title":"Nat Med"},{"key":"2820_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/mutage\/gew043","volume":"31","author":"S Alqahtani","year":"2016","unstructured":"Alqahtani S, Promtong P, Oliver AW, He XT, Walker TD, Povey A, et al. Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines. Mutagenesis. 2016;31:695\u2013702.","journal-title":"Mutagenesis"},{"key":"2820_CR30","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.3390\/cells11223619","volume":"11","author":"L Wieland","year":"2022","unstructured":"Wieland L, Schwarz T, Engel K, Volkmer I, Kruger A, Tarabuko A, et al. Epstein-Barr virus-induced genes and endogenous retroviruses in immortalized B cells from patients with multiple sclerosis. Cells. 2022;11:3619.","journal-title":"Cells"},{"key":"2820_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757302","volume":"12","author":"UC Meier","year":"2021","unstructured":"Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Front Immunol. 2021;12:757302.","journal-title":"Front Immunol"},{"key":"2820_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.molmed.2018.02.007","volume":"24","author":"P Kury","year":"2018","unstructured":"Kury P, Nath A, Creange A, Dolei A, Marche P, Gold J, et al. Human Endogenous retroviruses in neurological diseases. Trends Mol Med. 2018;24:379\u2013394.","journal-title":"Trends Mol Med"},{"key":"2820_CR33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/v12080852","volume":"12","author":"CH Liu","year":"2020","unstructured":"Liu CH, Grandi N, Palanivelu L, Tramontano E, Lin LT. et al. Contribution of human retroviruses to disease development: a focus on the HIV- and HERV-cancer relationships and treatment strategies. Viruses. 2020;12:852","journal-title":"Viruses"},{"key":"2820_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0114-y","volume":"8","author":"J Chen","year":"2019","unstructured":"Chen J, Foroozesh M, Qin Z. Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies. Oncogenesis. 2019;8:6.","journal-title":"Oncogenesis"},{"key":"2820_CR35","doi-asserted-by":"publisher","first-page":"e01507","DOI":"10.1128\/JVI.01507-17","volume":"92","author":"GR Young","year":"2018","unstructured":"Young GR, Terry SN, Manganaro L, Cuesta-Dominguez A, Deikus G, Bernal-Rubio D, et al. HIV-1 infection of primary CD4(.) T cells regulates the expression of specific human endogenous retrovirus HERV-K (HML-2) elements. J Virol. 2018;92:e01507\u201317.","journal-title":"J Virol"},{"key":"2820_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0156-6","volume":"12","author":"M Vincendeau","year":"2015","unstructured":"Vincendeau M, Gottesdorfer I, Schreml JM, Wetie AG, Mayer J, Greenwood AD, et al. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Retrovirology. 2015;12:27.","journal-title":"Retrovirology"},{"key":"2820_CR37","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1128\/JVI.00556-14","volume":"88","author":"MJ Gonzalez-Hernandez","year":"2014","unstructured":"Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, et al. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. J Virol. 2014;88:8924\u20138935.","journal-title":"J Virol"},{"key":"2820_CR38","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1038\/s41388-018-0282-4","volume":"37","author":"L Dai","year":"2018","unstructured":"Dai L, Del Valle L, Miley W, Whitby D, Ochoa AC, Flemington EK, et al. Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi\u2019s sarcoma development. Oncogene. 2018;37:4534\u20134545.","journal-title":"Oncogene"},{"key":"2820_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.708404","volume":"12","author":"TR Frey","year":"2021","unstructured":"Frey TR, Akinyemi IA, Burton EM, Bhaduri-McIntosh S, McIntosh MT. An ancestral retrovirus envelope protein regulates the persistent lifecycles of gammaherpesviruses. Front Microbiol. 2021;12:708404.","journal-title":"Front Microbiol"},{"key":"2820_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-132","volume":"10","author":"A Assinger","year":"2013","unstructured":"Assinger A, Yaiw KC, G\u00f6ttesdorfer I, Leib-M\u00f6sch C, S\u00f6derberg-Naucl\u00e9r C. Human cytomegalovirus (HCMV) induces human endogenous retrovirus (HERV) transcription. Retrovirology. 2013;10:132.","journal-title":"Retrovirology"},{"key":"2820_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jcv.2015.04.018","volume":"68","author":"M Bergallo","year":"2015","unstructured":"Bergallo M, Galliano I, Montanari P, Gambarino S, Mareschi K, Ferro F, et al. CMV induces HERV-K and HERV-W expression in kidney transplant recipients. J Clin Virol. 2015;68:28\u201331.","journal-title":"J Clin Virol"},{"key":"2820_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000490057","volume":"61","author":"M Bergallo","year":"2018","unstructured":"Bergallo M, Dapr\u00e0 V, Calvi C, Montanari P, Galliano I, Ravanini P. Is HERV-K and HERV-W expression regulated by mir-155 in kidney transplant patients with human cytomegalovirus infection? Intervirology. 2018;61:23\u201329.","journal-title":"Intervirology"},{"key":"2820_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semcancer.2010.05.005","volume":"20","author":"MT Romanish","year":"2010","unstructured":"Romanish MT, Cohen CJ, Mager DL. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol. 2010;20:246\u2013253.","journal-title":"Semin Cancer Biol"},{"key":"2820_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-genet-120213-092518","volume":"48","author":"E Brookes","year":"2014","unstructured":"Brookes E, Shi Y. Diverse epigenetic mechanisms of human disease. Annu Rev Genet. 2014;48:237\u2013268.","journal-title":"Annu Rev Genet"},{"key":"2820_CR45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.14348\/molcells.2021.5016","volume":"44","author":"S Durnaoglu","year":"2021","unstructured":"Durnaoglu S, Lee SK, Ahnn J. Human endogenous retroviruses as gene expression regulators: insights from animal models into human diseases. Mol Cells. 2021;44:861\u2013878.","journal-title":"Mol Cells"},{"key":"2820_CR46","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1021\/acs.est.8b06942","volume":"53","author":"X Huang","year":"2019","unstructured":"Huang X, Zhang B, Wu L, Zhou Y, Li Y, Mao X, et al. Association of exposure to ambient fine particulate matter constituents with semen quality among men attending a fertility center in China. Environ Sci Technol. 2019;53:5957\u20135965.","journal-title":"Environ Sci Technol"},{"key":"2820_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315\u2013322.","journal-title":"Nature"},{"key":"2820_CR48","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA, including endogenous retroviruses. Cell. 2015;162:974\u2013986.","journal-title":"Cell"},{"key":"2820_CR49","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/v12080884","volume":"12","author":"FK Geis","year":"2020","unstructured":"Geis FK, Goff SP. Silencing and transcriptional regulation of endogenous retroviruses: an overview. Viruses. 2020;12:884.","journal-title":"Viruses"},{"key":"2820_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones PA, Ohtani H, Chakravarthy A, De Carvalho DD. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19:151\u2013161.","journal-title":"Nat Rev Cancer"},{"key":"2820_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/gcc.20751","volume":"49","author":"S Stengel","year":"2010","unstructured":"Stengel S, Fiebig U, Kurth R, Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer. 2010;49:401\u2013411.","journal-title":"Genes Chromosomes Cancer"},{"key":"2820_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apm.12478","volume":"124","author":"F Li","year":"2016","unstructured":"Li F, Karlsson H. Expression and regulation of human endogenous retrovirus W elements. APMIS. 2016;124:52\u201366.","journal-title":"APMIS"},{"key":"2820_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.gene.2009.08.006","volume":"448","author":"S Szpakowski","year":"2009","unstructured":"Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene. 2009;448:151\u2013167.","journal-title":"Gene"},{"key":"2820_CR54","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/nar\/gkp1214","volume":"38","author":"J Gimenez","year":"2010","unstructured":"Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res. 2010;38:2229\u20132246.","journal-title":"Nucleic Acids Res"},{"key":"2820_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-3-12","volume":"3","author":"L Menendez","year":"2004","unstructured":"Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer. 2004;3:12.","journal-title":"Mol Cancer"},{"key":"2820_CR56","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1128\/JVI.79.2.876-883.2005","volume":"79","author":"L Lavie","year":"2005","unstructured":"Lavie L, Kitova M, Maldener E, Meese E, Mayer J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol. 2005;79:876\u2013883.","journal-title":"J Virol"},{"key":"2820_CR57","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1590\/S1415-47572009005000082","volume":"32","author":"Q Liang","year":"2009","unstructured":"Liang Q, Ding J, Zheng S. Identification and detection of a novel human endogenous retrovirus-related gene, and structural characterization of its related elements. Genet Mol Biol. 2009;32:704\u2013708.","journal-title":"Genet Mol Biol"},{"key":"2820_CR58","doi-asserted-by":"publisher","first-page":"e53895","DOI":"10.1371\/journal.pone.0053895","volume":"8","author":"MJ Laska","year":"2013","unstructured":"Laska MJ, Nissen KK, Nexo BA. Some cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1. PLoS ONE. 2013;8:e53895.","journal-title":"PLoS ONE"},{"key":"2820_CR59","doi-asserted-by":"publisher","first-page":"e20210789","DOI":"10.1084\/jem.20210789","volume":"219","author":"E Guo","year":"2022","unstructured":"Guo E, Xiao R, Wu Y, Lu F, Liu C, Yang B, et al. WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway. J Exp Med. 2022;219:e20210789.","journal-title":"J Exp Med"},{"key":"2820_CR60","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.1073\/pnas.1422187112","volume":"112","author":"PL Collins","year":"2015","unstructured":"Collins PL, Kyle KE, Egawa T, Shinkai Y, Oltz EM. The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes. Proc Natl Acad Sci USA. 2015;112:8367\u20138372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2820_CR61","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1101\/gr.234229.118","volume":"28","author":"H Ohtani","year":"2018","unstructured":"Ohtani H, Liu M, Zhou W, Liang G, Jones PA. Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses. Genome Res. 2018;28:1147\u20131157.","journal-title":"Genome Res"},{"key":"2820_CR62","doi-asserted-by":"publisher","first-page":"9456","DOI":"10.1093\/nar\/gky659","volume":"46","author":"D Rajagopalan","year":"2018","unstructured":"Rajagopalan D, Tirado-Magallanes R, Bhatia SS, Teo WS, Sian S, Hora S, et al. TIP60 represses activation of endogenous retroviral elements. Nucleic Acids Res. 2018;46:9456\u20139470.","journal-title":"Nucleic Acids Res"},{"key":"2820_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nm.2129","volume":"16","author":"B Lamprecht","year":"2010","unstructured":"Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med. 2010;16:571\u2013579.","journal-title":"Nat Med"},{"key":"2820_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17206-4","volume":"11","author":"O Deniz","year":"2020","unstructured":"Deniz O, Ahmed M, Todd CD, Rio-Machin A, Dawson MA, Branco MR. Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia. Nat Commun. 2020;11:3506.","journal-title":"Nat Commun"},{"key":"2820_CR65","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","volume":"12","author":"A Wong-Rolle","year":"2021","unstructured":"Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell. 2021;12:426\u2013435.","journal-title":"Protein Cell"},{"key":"2820_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2011.03.019","volume":"145","author":"RJ Gilbertson","year":"2011","unstructured":"Gilbertson RJ. Mapping cancer origins. Cell. 2011;145:25\u201329.","journal-title":"Cell"},{"key":"2820_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41576-020-0265-5","volume":"22","author":"AS Nam","year":"2021","unstructured":"Nam AS, Chaligne R, Landau DA. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nat Rev Genet. 2021;22:3\u201318.","journal-title":"Nat Rev Genet"},{"key":"2820_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-016-0080-x","volume":"7","author":"A Babaian","year":"2016","unstructured":"Babaian A, Mager DL. Endogenous retroviral promoter exaptation in human cancer. Mob DNA. 2016;7:24.","journal-title":"Mob DNA"},{"key":"2820_CR69","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/bioinformatics\/btn243","volume":"24","author":"AB Conley","year":"2008","unstructured":"Conley AB, Piriyapongsa J, Jordan IK. Retroviral promoters in the human genome. Bioinforma. 2008;24:1563\u20131567.","journal-title":"Bioinforma"},{"key":"2820_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.gene.2009.06.020","volume":"448","author":"CJ Cohen","year":"2009","unstructured":"Cohen CJ, Lock WM, Mager DL. Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene. 2009;448:105\u2013114.","journal-title":"Gene"},{"key":"2820_CR71","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41375-018-0311-x","volume":"33","author":"B Edginton-White","year":"2019","unstructured":"Edginton-White B, Cauchy P, Assi SA, Hartmann S, Riggs AG, Mathas S, et al. Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma. Leukemia. 2019;33:1463\u20131474.","journal-title":"Leukemia"},{"key":"2820_CR72","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fmicb.2018.00178","volume":"9","author":"N Bannert","year":"2018","unstructured":"Bannert N, Hofmann H, Block A, Hohn O. HERVs new role in cancer: from accused perpetrators to cheerful protectors. Front Microbiol. 2018;9:178.","journal-title":"Front Microbiol"},{"key":"2820_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-159","volume":"7","author":"AF Kessler","year":"2014","unstructured":"Kessler AF, Wiesner M, Denner J, K\u00e4mmerer U, Vince GH, Linsenmann T, et al. Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors. BMC Res Notes. 2014;7:159.","journal-title":"BMC Res Notes"},{"key":"2820_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat9820","volume":"5","author":"X Jin","year":"2019","unstructured":"Jin X, Xu XE, Jiang YZ, Liu YR, Sun W, Guo YJ, et al. The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Sci Adv. 2019;5:eaat9820.","journal-title":"Sci Adv"},{"key":"2820_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0142-6","volume":"7","author":"EA Gibb","year":"2015","unstructured":"Gibb EA, Warren RL, Wilson GW, Brown SD, Robertson GA, Morin GB, et al. Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma. Genome Med. 2015;7:22.","journal-title":"Genome Med"},{"key":"2820_CR76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng775","volume":"29","author":"JF Hughes","year":"2001","unstructured":"Hughes JF, Coffin JM. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet. 2001;29:487\u2013489.","journal-title":"Nat Genet"},{"key":"2820_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0074-4","volume":"12","author":"IM Campbell","year":"2014","unstructured":"Campbell IM, Gambin T, Dittwald P, Beck CR, Shuvarikov A, Hixson P, et al. Human endogenous retroviral elements promote genome instability via non-allelic homologous recombination. BMC Biol. 2014;12:74.","journal-title":"BMC Biol"},{"key":"2820_CR78","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","volume":"10","author":"PS Moore","year":"2010","unstructured":"Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10:878\u2013889.","journal-title":"Nat Rev Cancer"},{"key":"2820_CR79","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1128\/JVI.74.7.3321-3329.2000","volume":"74","author":"JL Blond","year":"2000","unstructured":"Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 2000;74:3321\u20133329.","journal-title":"J Virol"},{"key":"2820_CR80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.placenta.2021.01.006","volume":"113","author":"RM Roberts","year":"2021","unstructured":"Roberts RM, Ezashi T, Schulz LC, Sugimoto J, Schust DJ, Khan T, et al. Syncytins expressed in human placental trophoblast. Placenta. 2021;113:8\u201314.","journal-title":"Placenta"},{"key":"2820_CR81","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.celrep.2017.10.019","volume":"21","author":"X Lu","year":"2017","unstructured":"Lu X, Wang R, Zhu C, Wang H, Lin HY, Gu Y, et al. Fine-tuned and cell-cycle-restricted expression of fusogenic protein syncytin-2 maintains functional placental syncytia. Cell Rep. 2017;21:1150\u20131159.","journal-title":"Cell Rep"},{"key":"2820_CR82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/1477-3163.109032","volume":"12","author":"G Huang","year":"2013","unstructured":"Huang G, Li Z, Wan X, Wang Y, Dong J. Human endogenous retroviral K element encodes fusogenic activity in melanoma cells. J Carcinog. 2013;12:5.","journal-title":"J Carcinog"},{"key":"2820_CR83","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1073\/pnas.0707873105","volume":"104","author":"M Mangeney","year":"2007","unstructured":"Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA. 2007;104:20534\u201320539.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2820_CR84","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/eji.201445366","volume":"45","author":"J Hummel","year":"2015","unstructured":"Hummel J, K\u00e4mmerer U, M\u00fcller N, Avota E, Schneider-Schaulies S. Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation. Eur J Immunol. 2015;45:1748\u20131759.","journal-title":"Eur J Immunol"},{"key":"2820_CR85","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/19768354.2021.2019109","volume":"25","author":"S Durnaoglu","year":"2021","unstructured":"Durnaoglu S, Lee SK, Ahnn J. Syncytin, envelope protein of human endogenous retrovirus (HERV): no longer \u201cfossil\u201d in human genome. Anim Cell Syst. 2021;25:358\u2013368.","journal-title":"Anim Cell Syst"},{"key":"2820_CR86","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1158\/0008-5472.CAN-20-3975","volume":"81","author":"MC Steiner","year":"2021","unstructured":"Steiner MC, Marston JL, I\u00f1iguez LP, Bendall ML, Chiappinelli KB, Nixon DF, et al. Locus-specific characterization of human endogenous retrovirus expression in prostate, breast, and colon cancers. Cancer Res. 2021;81:3449\u20133460.","journal-title":"Cancer Res"},{"key":"2820_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fonc.2013.00180","volume":"3","author":"L Agoni","year":"2013","unstructured":"Agoni L, Guha C, Lenz J. Detection of human endogenous retrovirus k (HERV-k) transcripts in human prostate cancer cell Lines. Front Oncol. 2013;3:180.","journal-title":"Front Oncol"},{"key":"2820_CR88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cncr.11451","volume":"98","author":"F Wang-Johanning","year":"2003","unstructured":"Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, et al. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer. 2003;98:187\u2013197.","journal-title":"Cancer"},{"key":"2820_CR89","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/carcin\/bgr181","volume":"32","author":"W Goering","year":"2011","unstructured":"Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis. 2011;32:1484\u20131492.","journal-title":"Carcinogenesis"},{"key":"2820_CR90","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature06024","volume":"448","author":"SA Tomlins","year":"2007","unstructured":"Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448:595\u2013599.","journal-title":"Nature"},{"key":"2820_CR91","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","volume":"17","author":"J Yu","year":"2010","unstructured":"Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell. 2010;17:443\u2013454.","journal-title":"Cancer Cell"},{"key":"2820_CR92","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1158\/1078-0432.CCR-12-3580","volume":"19","author":"BS Reis","year":"2013","unstructured":"Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, et al. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res. 2013;19:6112\u20136125.","journal-title":"Clin Cancer Res"},{"key":"2820_CR93","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/pros.23095","volume":"75","author":"W Goering","year":"2015","unstructured":"Goering W, Schmitt K, Dostert M, Schaal H, Deenen R, Mayer J, et al. Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci. Prostate. 2015;75:1958\u20131971.","journal-title":"Prostate"},{"key":"2820_CR94","doi-asserted-by":"publisher","first-page":"e76472","DOI":"10.1371\/journal.pone.0076472","volume":"8","author":"L Agoni","year":"2013","unstructured":"Agoni L, Lenz J, Guha C. Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines. PLoS ONE. 2013;8:e76472.","journal-title":"PLoS ONE"},{"key":"2820_CR95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/aid.2006.22.52","volume":"22","author":"S Rakoff-Nahoum","year":"2006","unstructured":"Rakoff-Nahoum S, Kuebler PJ, Heymann JJ. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res Hum Retrovir. 2006;22:52\u201356.","journal-title":"AIDS Res Hum Retrovir"},{"key":"2820_CR96","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-07-6838","volume":"68","author":"F Wang-Johanning","year":"2008","unstructured":"Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008;68:5869\u20135877.","journal-title":"Cancer Res"},{"key":"2820_CR97","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5213\/inj.2244284.142","volume":"26","author":"SK Lee","year":"2022","unstructured":"Lee SK, Kim SH, Ahnn J. Human endogenous retroviruses: friends and foes in urology clinics. Int Neurourol J. 2022;26:275\u2013287.","journal-title":"Int Neurourol J"},{"key":"2820_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115017","volume":"397","author":"BA Merrick","year":"2020","unstructured":"Merrick BA, Phadke DP, Bostrom MA, Shah RR, Wright GM, Wang X, et al. KRAS-retroviral fusion transcripts and gene amplification in arsenic-transformed, human prostate CAsE-PE cancer cells. Toxicol Appl Pharmacol. 2020;397:115017.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2820_CR99","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/ijerph17030960","volume":"17","author":"J Ahn","year":"2020","unstructured":"Ahn J, Boroje IJ, Ferdosi H, Kramer ZJ, Lamm SH. Prostate cancer incidence in U.S. counties and low levels of arsenic in drinking water. Int J Environ Res Public Health. 2020;17:960.","journal-title":"Int J Environ Res Public Health"},{"key":"2820_CR100","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.mehy.2010.10.042","volume":"76","author":"M Rubenstein","year":"2011","unstructured":"Rubenstein M, Hollowell CM, Guinan P. Does the prostate retain an endogenous antiviral defense system suggesting a past viral etiology for cancer?. Med Hypotheses. 2011;76:368\u2013370.","journal-title":"Med Hypotheses"},{"key":"2820_CR101","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1093\/nar\/gkl968","volume":"34","author":"RJ Molinaro","year":"2006","unstructured":"Molinaro RJ, Jha BK, Malathi K, Varambally S, Chinnaiyan AM, Silverman RH. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2\u2019,5\u2019-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res. 2006;34:6684\u20136695.","journal-title":"Nucleic Acids Res"},{"key":"2820_CR102","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1158\/0008-5472.CAN-15-3139","volume":"76","author":"E Cherkasova","year":"2016","unstructured":"Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, et al. Detection of an immunogenic HERV-E envelope with selective expression in clear cell kidney cancer. Cancer Res. 2016;76:2177\u20132185.","journal-title":"Cancer Res"},{"key":"2820_CR103","doi-asserted-by":"publisher","first-page":"e167712","DOI":"10.1172\/jci.insight.167712","volume":"8","author":"S Kobayashi","year":"2023","unstructured":"Kobayashi S, Tokita S, Moniwa K, Kitahara K, Iuchi H, Matsuo K, et al. Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma. JCI Insight. 2023;8:e167712.","journal-title":"JCI Insight"},{"key":"2820_CR104","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.cell.2025.01.046","volume":"188","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Braun DA, Clauser KR, Ramesh V, Shirole NH, Duke-Cohan JE, et al. HIF regulates multiple translated endogenous retroviruses: implications for cancer immunotherapy. Cell. 2025;188:1807\u20131827.e1834.","journal-title":"Cell"},{"key":"2820_CR105","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ccell.2021.10.001","volume":"39","author":"L Au","year":"2021","unstructured":"Au L, Hatipoglu E, Robert de Massy M, Litchfield K, Beattie G, Rowan A, et al. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell. 2021;39:1497\u20131518.e1411.","journal-title":"Cancer Cell"},{"key":"2820_CR106","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature15258","volume":"526","author":"T Wiesner","year":"2015","unstructured":"Wiesner T, Lee W, Obenauf AC, Ran L, Murali R, Zhang QF, et al. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer. Nature. 2015;526:453\u2013457.","journal-title":"Nature"},{"key":"2820_CR107","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ebiom.2019.01.063","volume":"41","author":"KT Siebenthall","year":"2019","unstructured":"Siebenthall KT, Miller CP, Vierstra JD, Mathieu J, Tretiakova M, Reynolds A, et al. Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma. EBioMedicine. 2019;41:427\u2013442.","journal-title":"EBioMedicine"},{"key":"2820_CR108","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.2147\/OTT.S259534","volume":"13","author":"W Cao","year":"2020","unstructured":"Cao W, Kang R, Xiang Y, Hong J. Human endogenous retroviruses in clear cell renal cell carcinoma: biological functions and clinical values. Onco Targets Ther. 2020;13:7877\u20137885.","journal-title":"Onco Targets Ther"},{"key":"2820_CR109","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43\u201349.","DOI":"10.1038\/nature12222"},{"key":"2820_CR110","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1001\/jamaoncol.2019.3158","volume":"5","author":"DA Braun","year":"2019","unstructured":"Braun DA, Ishii Y, Walsh AM, Van Allen EM, Wu CJ, Shukla SA, et al. Clinical validation of pbrm1 alterations as a marker of immune checkpoint inhibitor response in renal cell carcinoma. JAMA Oncol. 2019;5:1631\u20131633.","journal-title":"JAMA Oncol"},{"key":"2820_CR111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1158\/2326-6066.CIR-21-0480","volume":"10","author":"M Zhou","year":"2022","unstructured":"Zhou M, Leung JY, Gessner KH, Hepperla AJ, Simon JM, Davis IJ, et al. PBRM1 inactivation promotes upregulation of human endogenous retroviruses in a HIF-dependent manner. Cancer Immunol Res. 2022;10:285\u2013290.","journal-title":"Cancer Immunol Res"},{"key":"2820_CR112","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/2326-6066.CIR-22-0058","volume":"10","author":"C Labaki","year":"2022","unstructured":"Labaki C, Van Allen EM, Choueiri TK. Linking a trio of molecular features in clear-cell renal cell carcinoma. Cancer Immunol Res. 2022;10:274.","journal-title":"Cancer Immunol Res"},{"key":"2820_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11496-9","volume":"23","author":"T Shigemura","year":"2023","unstructured":"Shigemura T, Perrot N, Huang Z, Bhatt RS, Sheshdeh AB, Ahmar NE, et al. Regulation of HHLA2 expression in kidney cancer and myeloid cells. BMC Cancer. 2023;23:1039.","journal-title":"BMC Cancer"},{"key":"2820_CR114","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.aan5951","volume":"359","author":"D Miao","year":"2018","unstructured":"Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science. 2018;359:801\u2013806.","journal-title":"Science"},{"key":"2820_CR115","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","volume":"14","author":"P Kapur","year":"2013","unstructured":"Kapur P, Pe\u00f1a-Llopis S, Christie A, Zhrebker L, Pav\u00eda-Jim\u00e9nez A, Rathmell WK, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol. 2013;14:159\u2013167.","journal-title":"Lancet Oncol"},{"key":"2820_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04760-6","volume":"13","author":"W Liu","year":"2022","unstructured":"Liu W, Zhang B, Zhang D, Guo F, Ye K, Zhu L, et al. The RBPJ\/DAPK3\/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4\/6 inhibitors. Cell Death Dis. 2022;13:295.","journal-title":"Cell Death Dis"},{"key":"2820_CR117","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1101\/gad.349249.121","volume":"36","author":"H Feng","year":"2022","unstructured":"Feng H, Lane KA, Roumeliotis TI, Jeggo PA, Somaiah N, Choudhary JS, et al. PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2\/M checkpoint maintenance. Genes Dev. 2022;36:790\u2013806.","journal-title":"Genes Dev"},{"key":"2820_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02245-1","volume":"8","author":"J Espana-Agusti","year":"2017","unstructured":"Espana-Agusti J, Warren A, Chew SK, Adams DJ, Matakidou A. Loss of PBRM1 rescues VHL-dependent replication stress to promote renal carcinogenesis. Nat Commun. 2017;8:2026.","journal-title":"Nat Commun"},{"key":"2820_CR119","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1038\/onc.2011.179","volume":"30","author":"E Cherkasova","year":"2011","unstructured":"Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, et al. Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene. 2011;30:4697\u20134706.","journal-title":"Oncogene"},{"key":"2820_CR120","doi-asserted-by":"publisher","first-page":"e009147","DOI":"10.1136\/jitc-2024-009147","volume":"12","author":"S Barisic","year":"2024","unstructured":"Barisic S, Brahmbhatt EM, Cherkasova E, Spear TT, Savani U, Pierre S, et al. Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus. J Immunother Cancer. 2024;12:e009147.","journal-title":"J Immunother Cancer"},{"key":"2820_CR121","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"2820_CR122","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1038\/onc.2013.366","volume":"33","author":"H Yu","year":"2014","unstructured":"Yu H, Liu T, Zhao Z, Chen Y, Zeng J, Liu S, et al. Mutations in 3\u2019-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. Oncogene. 2014;33:3947\u20133958.","journal-title":"Oncogene"},{"key":"2820_CR123","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.juro.2014.12.031","volume":"193","author":"A Atala","year":"2015","unstructured":"Atala A. Re: Mutations in 3\u2019-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. J Urol. 2015;193:1061.","journal-title":"J Urol"},{"key":"2820_CR124","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/genes14071410","volume":"14","author":"EG Park","year":"2023","unstructured":"Park EG, Lee DH, Kim WR, Lee YJ, Bae WH, Kim JM. et al. Human endogenous retrovirus-h-derived MIR-4454 inhibits theexpression of DNAJB4 and sash1 in non-muscle-invasive bladder cancer. Genes. 2023;14:1410","journal-title":"Genes"},{"key":"2820_CR125","doi-asserted-by":"publisher","first-page":"e49341","DOI":"10.1371\/journal.pone.0049341","volume":"7","author":"D Gosenca","year":"2012","unstructured":"Gosenca D, Gabriel U, Steidler A, Mayer J, Diem O, Erben P, et al. HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinoma. PLoS ONE. 2012;7:e49341.","journal-title":"PLoS ONE"},{"key":"2820_CR126","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/aid.2010.0014","volume":"26","author":"U Gabriel","year":"2010","unstructured":"Gabriel U, Steidler A, Trojan L, Michel MS, Seifarth W, Fabarius A. Smoking increases transcription of human endogenous retroviruses in a newly established in vitro cell model and in normal urothelium. AIDS Res Hum Retrovir. 2010;26:883\u2013888.","journal-title":"AIDS Res Hum Retrovir"},{"key":"2820_CR127","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/551S33a","volume":"551","author":"M Grayson","year":"2017","unstructured":"Grayson M. Bladder cancer. Nature. 2017;551:S33.","journal-title":"Nature"},{"key":"2820_CR128","first-page":"e070499","volume":"379","author":"M Chovanec","year":"2022","unstructured":"Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ (Clin Res ed). 2022;379:e070499.","journal-title":"BMJ (Clin Res ed)"},{"key":"2820_CR129","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","volume":"4","author":"L Cheng","year":"2018","unstructured":"Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, et al. Testicular cancer. Nat Rev Dis Prim. 2018;4:29.","journal-title":"Nat Rev Dis Prim"},{"key":"2820_CR130","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg J, Berney DM, Bokemeyer C, Climent MA, Daugaard G, Gietema JA, et al. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol J Eur Soc Med Oncol. 2022;33:362\u2013375.","journal-title":"Ann Oncol J Eur Soc Med Oncol"},{"key":"2820_CR131","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s004280050298","volume":"434","author":"H Herbst","year":"1999","unstructured":"Herbst H, K\u00fchler-Obbarius C, Lauke H, Sauter M, Mueller-Lantzsch N, Harms D, et al. Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch. 1999;434:11\u20135.","journal-title":"Virchows Arch"},{"key":"2820_CR132","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00438-001-0596-7","volume":"266","author":"T Vinogradova","year":"2002","unstructured":"Vinogradova T, Leppik L, Kalinina E, Zhulidov P, Grzeschik KH, Sverdlov E. Selective differential display of RNAs containing interspersed repeats: analysis of changes in the transcription of HERV-K LTRS in germ cell tumors. Mol Genet Genom. 2002;266:796\u2013805.","journal-title":"Mol Genet Genom"},{"key":"2820_CR133","first-page":"17","volume":"51","author":"NB Seniuta","year":"2006","unstructured":"Seniuta NB, Kle\u012dman AM, Triakin AA, Karseladze AI, Shelepova VM, Tiuliandin SA, et al. Antibodies to structural proteins of endogenous retrovirus of the HERV-K\/HTDV family as markers of human germ cell tumors. Vopr Virusol. 2006;51:17\u201321.","journal-title":"Vopr Virusol"},{"key":"2820_CR134","first-page":"15","volume":"46","author":"AM Kle\u012dman","year":"2001","unstructured":"Kle\u012dman AM, Seniuta NB, Triakin AA, Vinogradova TV, Karseladze AI, Souther M, et al. Expression of endogenous retroviruses of the HERV-K\/HTDV family in patient with germinogenic tongue tumors. Vopr Virusol. 2001;46:15\u201321.","journal-title":"Vopr Virusol"},{"key":"2820_CR135","first-page":"293","volume":"8","author":"JJ Goedert","year":"1999","unstructured":"Goedert JJ, Sauter ME, Jacobson LP, Vessella RL, Hilgartner MW, Leitman SF, et al. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS. Cancer Epidemiol Biomark Prev. 1999;8:293\u2013296.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2820_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-17","volume":"6","author":"A Ruggieri","year":"2009","unstructured":"Ruggieri A, Maldener E, Sauter M, Mueller-Lantzsch N, Meese E, Fackler OT, et al. Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec. Retrovirology. 2009;6:17.","journal-title":"Retrovirology"},{"key":"2820_CR137","doi-asserted-by":"publisher","first-page":"E8580","DOI":"10.1073\/pnas.1803292115","volume":"115","author":"MC Haffner","year":"2018","unstructured":"Haffner MC, Taheri D, Luidy-Imada E, Palsgrove DN, Eich ML, Netto GJ, et al. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci USA. 2018;115:E8580\u2013E8582.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2820_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0342-9","volume":"14","author":"M Bene\u0161ov\u00e1","year":"2017","unstructured":"Bene\u0161ov\u00e1 M, Trejbalov\u00e1 K, Kov\u00e1\u0159ov\u00e1 D, Vernerov\u00e1 Z, Hron T, Ku\u010derov\u00e1 D, et al. DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1\/syncytin-1 in seminomas. Retrovirology. 2017;14:20.","journal-title":"Retrovirology"},{"key":"2820_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02230-y","volume":"20","author":"SWD Merriel","year":"2022","unstructured":"Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022;20:54.","journal-title":"BMC Med"},{"key":"2820_CR140","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1515\/cclm-2019-0693","volume":"58","author":"MJ Duffy","year":"2020","unstructured":"Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020;58:326\u2013339.","journal-title":"Clin Chem Lab Med"},{"key":"2820_CR141","first-page":"e50713.","volume":"81","author":"P Perot","year":"2013","unstructured":"Perot P, Cheynet V, Decaussin-Petrucci M, Oriol G, Mugnier N, Rodriguez-Lafrasse C, et al. Microarray-based identification of individual HERV loci expression: application to biomarker discovery in prostate cancer. J Vis Exp. 2013;81:e50713.","journal-title":"J Vis Exp"},{"key":"2820_CR142","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/carcin\/bgu114","volume":"35","author":"TA Wallace","year":"2014","unstructured":"Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, et al. Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis, particularly in older men and smokers. Carcinogenesis. 2014;35:2074\u20132083.","journal-title":"Carcinogenesis"},{"key":"2820_CR143","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/v13030449","volume":"13","author":"SD Rezaei","year":"2021","unstructured":"Rezaei SD, Hayward JA, Norden S, Pedersen J, Mills J, Hearps AC, et al. HERV-K Gag RNA and protein levels are elevated in malignant regions of the prostate in males with prostate cancer. Viruses. 2021;13:449.","journal-title":"Viruses"},{"key":"2820_CR144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/pathogens11010095","volume":"11","author":"MA Manca","year":"2022","unstructured":"Manca MA, Solinas T, Simula ER, Noli M, Ruberto S, Madonia M, et al. HERV-K and HERV-H Env proteins induce a humoral response in prostate cancer patients. Pathogens. 2022;11:95.","journal-title":"Pathogens"},{"key":"2820_CR145","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2174\/138161207780249191","volume":"13","author":"M Landriscina","year":"2007","unstructured":"Landriscina M, Spadafora C, Cignarelli M, Barone C. Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors. Curr Pharm Des. 2007;13:737\u2013747.","journal-title":"Curr Pharm Des"},{"key":"2820_CR146","doi-asserted-by":"publisher","first-page":"e14221","DOI":"10.1371\/journal.pone.0014221","volume":"5","author":"F Carlini","year":"2010","unstructured":"Carlini F, Ridolfi B, Molinari A, Parisi C, Bozzuto G, Toccacieli L, et al. The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines. PLoS ONE. 2010;5:e14221.","journal-title":"PLoS ONE"},{"key":"2820_CR147","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/14728222.2017.1373095","volume":"21","author":"WA Schulz","year":"2017","unstructured":"Schulz WA. Does HERV-K represent a potential therapeutic target for prostate cancer?. Expert Opin Ther Targets. 2017;21:921\u2013924.","journal-title":"Expert Opin Ther Targets"},{"key":"2820_CR148","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00018-022-04294-2","volume":"79","author":"C Bu","year":"2022","unstructured":"Bu C, Wang Z, Ren Y, Chen D, Jiang SW. Syncytin-1 nonfusogenic activities modulate inflammation and contribute to preeclampsia pathogenesis. Cell Mol Life Sci. 2022;79:290.","journal-title":"Cell Mol Life Sci"},{"key":"2820_CR149","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/humrep\/dew097","volume":"31","author":"B Soygur","year":"2016","unstructured":"Soygur B, Moore H. Expression of Syncytin 1 (HERV-W), in the preimplantation human blastocyst, embryonic stem cells and trophoblast cells derived in vitro. Hum Reprod. 2016;31:1455\u20131461.","journal-title":"Hum Reprod"},{"key":"2820_CR150","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jnci\/djr540","volume":"104","author":"F Wang-Johanning","year":"2012","unstructured":"Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst. 2012;104:189\u2013210.","journal-title":"J Natl Cancer Inst"},{"key":"2820_CR151","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010386","volume":"13","author":"X Lu","year":"2025","unstructured":"Lu X, Vano YA, Su X, Verkarre V, Sun CM, Cheng W, et al. Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma. J Immunother Cancer. 2025;13:e010386.","journal-title":"J Immunother Cancer"},{"key":"2820_CR152","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jmedgenet-2018-105454","volume":"56","author":"D Chen","year":"2019","unstructured":"Chen D, Chen W, Xu Y, Zhu M, Xiao Y, Shen Y, et al. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target. J Med Genet. 2019;56:43\u201349.","journal-title":"J Med Genet"},{"key":"2820_CR153","doi-asserted-by":"publisher","first-page":"e72756","DOI":"10.1371\/journal.pone.0072756","volume":"8","author":"B Kraus","year":"2013","unstructured":"Kraus B, Fischer K, B\u00fcchner SM, Wels WS, L\u00f6wer R, Sliva K, et al. Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system. PLoS ONE. 2013;8:e72756.","journal-title":"PLoS ONE"},{"key":"2820_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-58","volume":"11","author":"B Kraus","year":"2014","unstructured":"Kraus B, Fischer K, Sliva K, Schnierle BS. Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag-expressing cell growth in a murine model system. Virol J. 2014;11:58.","journal-title":"Virol J"},{"key":"2820_CR155","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-14-3197","volume":"21","author":"J Krishnamurthy","year":"2015","unstructured":"Krishnamurthy J, Rabinovich BA, Mi T, Switzer KC, Olivares S, Maiti SN, et al. Genetic engineering of T cells to target HERV-K, an ancient retrovirus in melanoma. Clin Cancer Res. 2015;21:3241\u20133251.","journal-title":"Clin Cancer Res"},{"key":"2820_CR156","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1172\/JCI121476","volume":"128","author":"CC Smith","year":"2018","unstructured":"Smith CC, Beckermann KE, Bortone DS, De Cubas AA, Bixby LM, Lee SJ, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. J Clin Investig. 2018;128:4804\u20134820.","journal-title":"J Clin Investig"},{"key":"2820_CR157","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419833574","volume":"12","author":"M Diebold","year":"2019","unstructured":"Diebold M, Derfuss T. The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis. Ther Adv Neurol Disord. 2019;12:1756286419833574.","journal-title":"Ther Adv Neurol Disord"},{"key":"2820_CR158","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2015.05.019","volume":"285","author":"T Derfuss","year":"2015","unstructured":"Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, et al. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients - a twelve-month follow-up. J Neuroimmunol. 2015;285:68\u201370.","journal-title":"J Neuroimmunol"},{"key":"2820_CR159","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/1078-0432.CCR-20-3084","volume":"27","author":"M Ficial","year":"2021","unstructured":"Ficial M, Jegede OA, Sant\u2019Angelo M, Hou Y, Flaifel A, Pignon JC, et al. Expression of T-cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to nivolumab in metastatic clear cell renal cell carcinoma. Clin Cancer Res. 2021;27:1371\u20131380.","journal-title":"Clin Cancer Res"},{"key":"2820_CR160","doi-asserted-by":"publisher","first-page":"e121522","DOI":"10.1172\/jci.insight.121522","volume":"3","author":"A Panda","year":"2018","unstructured":"Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, et al. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight. 2018;3:e121522.","journal-title":"JCI Insight"},{"key":"2820_CR161","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 2015;162:961\u2013973.","journal-title":"Cell"},{"key":"2820_CR162","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","volume":"3","author":"L Wang","year":"2015","unstructured":"Wang L, Amoozgar Z, Huang J, Saleh MH, Xing D, Orsulic S, et al. Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model. Cancer Immunol Res. 2015;3:1030\u20131041.","journal-title":"Cancer Immunol Res"},{"key":"2820_CR163","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000495887","volume":"141","author":"G Lin","year":"2019","unstructured":"Lin G, Ye H, Wang J, Chen S, Chen X, Zhang C. Immune checkpoint human endogenous retrovirus-h long terminal repeat-associating protein 2 is upregulated and independently predicts unfavorable prognosis in bladder urothelial carcinoma. Nephron. 2019;141:256\u2013264.","journal-title":"Nephron"},{"key":"2820_CR164","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-06-0134","volume":"12","author":"XS Wang","year":"2006","unstructured":"Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12:4851\u20134858.","journal-title":"Clin Cancer Res"},{"key":"2820_CR165","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ijc.29003","volume":"137","author":"RF Downey","year":"2015","unstructured":"Downey RF, Sullivan FJ, Wang-Johanning F, Ambs S, Giles FJ, Glynn SA. Human endogenous retrovirus K and cancer: innocent bystander or tumorigenic accomplice? Int J Cancer. 2015;137:1249\u20131257.","journal-title":"Int J Cancer"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02820-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:02:28Z","timestamp":1764345748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2820"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02820-2","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors approved the final version of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"553"}}